Main reason for the overselling is due to the China lockdowns impacting the company contracted to produce the drug. Not a fundamental sell down in any way, just market sentiment. At the current price this is a screaming buy.
- Forums
- ASX - By Stock
- Ann: European Patent to be Granted for Cholesterol-Lowering Drug
Main reason for the overselling is due to the China lockdowns...
Featured News
Add NYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
-0.001(1.59%) |
Mkt cap ! $11.12M |
Open | High | Low | Value | Volume |
6.3¢ | 6.5¢ | 6.2¢ | $3.61K | 56.74K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.2¢ | 80 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.061 |
5 | 269350 | 0.060 |
1 | 20000 | 0.059 |
1 | 260000 | 0.058 |
1 | 100000 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.062 | 80 | 1 |
0.063 | 82991 | 1 |
0.070 | 152870 | 2 |
0.080 | 25000 | 1 |
0.081 | 245106 | 1 |
Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
6.3¢ |
  |
Change
-0.001 ( 1.56 %) |
|||
Open | High | Low | Volume | ||
6.3¢ | 6.3¢ | 6.3¢ | 43043 | ||
Last updated 15.09pm 24/05/2024 ? |
Featured News
NYR (ASX) Chart |